Abstract

Introduction: Combat-related posttraumatic stress disorder (PTSD) is increasingly conceptualized in psychiatry as a disorder of dysfunctional neural circuits. Advances in neuroimaging have enabled the study of those networks non-invasively. PTSD is currently assessed using subjective self-reporting to inform crucial decisions, such as fitness to deploy, but objective markers would aid in diagnosis and return-to-deployment decisions. Methods: Magnetoencephalography (MEG) allows investigation of neural circuit function via imaging of brain waves (known as neural oscillations) that index information processing in the brain and would prove a reliable, objective, biomarker. These measures of brain function establish how regions communicate to form brain circuits that support thinking and behaviour. Results: Studies into intrinsic brain function, both during rest and when engaged in a task designed to tap into cognitive dysfunction, have found these neurobiological mechanisms are disrupted in PTSD and are a reliable objective marker of illness. We now know that these alterations in brain function are directly related to core symptoms of PTSD and comorbid cognitive-behavioural challenges. Discussion: Continued characterization of neural function using MEG and related methods will advance understanding of the neurobiology underlying PTSD; allow for the identification of biomarkers that, coupled with machine learning, will aid in diagnoses; provide individualized therapeutic targets for neurostimulation; predict treatment outcomes; and track disorder remission in military personnel and Veterans who are disproportionately affected by this devastating illness.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call